ROKAMED
InactiveInactive since 21-08-2026; last annual accounts for fiscal year 2025. Dissolved and wound up in a single deed on 13-08-2026.
Signals
This company filed its last 4 accounts on average 23 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €3,374 | €2,084 | €796 | - | - |
| Other operating charges640/8 | - | €99 | €103 | - | - |
| Gross operating margin9900 | €91,255 | -€6,251 | €19,552 | €17,106 | ▼ 12.5% |
| Operating profit (loss)9901 | €87,881 | -€8,434 | €18,653 | €17,106 | ▼ 8.3% |
| Financial income75/76B | €95 | €2,417 | €3,199 | €1,980 | ▼ 38.1% |
| Recurring financial income75 | €95 | €2,417 | €3,199 | €1,980 | ▼ 38.1% |
| Financial charges65/66B | €105 | €39 | €43 | €61 | ▲ 42.1% |
| Recurring financial charges65 | €105 | €39 | €43 | €61 | ▲ 42.1% |
| Profit (loss) for the period before taxes9903 | €87,871 | -€6,057 | €21,809 | €19,025 | ▼ 12.8% |
| Income taxes67/77 | €24,352 | - | €4,784 | €5,490 | ▲ 14.7% |
| Profit (loss) for the period9904 | €63,520 | -€6,057 | €17,025 | €13,535 | ▼ 20.5% |
| Profit (loss) for the period to be appropriated9905 | €63,520 | -€6,057 | €17,025 | €13,535 | ▼ 20.5% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €91,672 | €86,223 | €83,432 | €96,863 | ▲ 16.1% |
| Fixed assets21/28 | €3,580 | €1,496 | €700 | €700 | = |
| Tangible fixed assets22/27 | €2,880 | €796 | - | - | - |
| Plant, machinery and equipment23 | €2,082 | €430 | - | - | - |
| Furniture and vehicles24 | €798 | €365 | - | - | - |
| Financial fixed assets28 | €700 | €700 | €700 | €700 | = |
| Current assets29/58 | €88,092 | €84,728 | €82,732 | €96,163 | ▲ 16.2% |
| Amounts receivable within one year40/41 | €35,456 | €58,803 | €67,469 | €83,195 | ▲ 23.3% |
| Trade receivables40 | - | €3,550 | €32,195 | €35,590 | ▲ 10.5% |
| Other amounts receivable41 | €35,456 | €55,253 | €35,274 | €47,605 | ▲ 35.0% |
| Cash at bank and in hand54/58 | €52,636 | €25,924 | €15,263 | €12,968 | ▼ 15.0% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €91,672 | €86,223 | €83,432 | €96,863 | ▲ 16.1% |
| Equity10/15 | €64,520 | €58,463 | €75,487 | €89,022 | ▲ 17.9% |
| Contributions10/11 | €1,000 | €1,000 | €1,000 | €1,000 | = |
| Reserves13 | €63,520 | €63,520 | €74,487 | €87,522 | ▲ 17.5% |
| Distributable reserves133 | €63,520 | €63,520 | €74,487 | €87,522 | ▲ 17.5% |
| Profit (loss) carried forward14 | - | -€6,057 | - | €500 | - |
| Amounts payable17/49 | €27,153 | €27,761 | €7,944 | €7,840 | ▼ 1.3% |
| Amounts payable within one year42/48 | €27,153 | €27,761 | €7,944 | €7,840 | ▼ 1.3% |
| Trade debts44 | €2,801 | €2,834 | €2,634 | €6,471 | ▲ 146% |
| Suppliers440/4 | €2,801 | €2,834 | €2,634 | €6,471 | ▲ 146% |
| Taxes, remuneration and social security45 | €24,352 | €24,927 | €5,310 | €1,369 | ▼ 74.2% |
| Taxes450/3 | €24,352 | €24,927 | €5,310 | €1,369 | ▼ 74.2% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €63,520 | -€6,057 | €17,025 | €13,535 | ▼ 20.5% |
| + Depreciation and write-downs630 | €3,374 | €2,084 | €796 | - | - |
| Operating cash flow (approximation) | €66,893 | -€3,972 | €17,820 | €13,535 | ▼ 24.0% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | - |
| Change in cash | - | -€26,712 | -€10,661 | -€2,295 | ▲ 78.5% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
31-08
State Gazette act
Rubrik Ende (Einstellung, Widerruf Einstellung, Nichtigkeit, Usw...)Auditor report · Dissolution · Liquidation closure10 facts ▸
- General meeting, 13-08-2026
- General meeting, Berichte zur Kenntnis genommen und einstimmig angenommen, 31-05-2026
- Auditor report, 88417.49, Uneingeschränkter Bestätigungsvermerk
- Dissolution, 13-08-2026
- Liquidation closure, 13-08-2026
- Declaration, keine Immobilien oder andere unbewegliche Rechte in den Aktiva
- Power of attorney, Sven BOCKEN
- Power of attorney, KROTT Marie
- Other statement, 11:15, Sitzungsende
- Other statement, Verwaltung, officer resignation
About the unread acts
Of the 3 Belgian State Gazette acts we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Articles of association
Structure & network
Owners and holdings
1 holdingOwners 0
The accounts to 31-12-2025 list no shareholders, and no other source names one.
Holdings 1
-
50%
According to the 2025 annual accounts of ROKAMED and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
Identification & contact
No Peppol card under this enterprise or VAT number. That proves nothing: publishing a card is voluntary.
Register as of 30 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.